Cargando…

An Update on Contraception in Polycystic Ovary Syndrome

Polycystic ovary syndrome (PCOS) is a common endocrine disorder in reproductive-aged women, characterized by hyperandrogenism, oligo/anovulation, and polycystic ovarian morphology. Combined oral contraceptives (COCs), along with lifestyle modifications, represent the first-line medical treatment for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oguz, Seda Hanife, Yildiz, Bulent Okan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Endocrine Society 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090477/ https://www.ncbi.nlm.nih.gov/pubmed/33853290 http://dx.doi.org/10.3803/EnM.2021.958

Ejemplares similares

Beneficial outcomes of glucagon like peptide-1 agonist therapy in a patient with Bardet Biedl syndrome and kidney transplant
por: Erturk, Banu, et al.
Publicado: (2023)

Aging versus youth: Endocrine aspects of vulnerability for COVID-19
por: Oguz, Seda Hanife, et al.
Publicado: (2021)

Update on polycystic ovary syndrome
por: Kim, Jin Ju
Publicado: (2021)

Lifestyle and Weight Change in Women With Polycystic Ovary Syndrome During COVID19 Pandemic
por: Eyupoglu, Nesrin Damla, et al.
Publicado: (2021)

Polycystic ovary syndrome and the risk of obstructive sleep apnea: a meta-analysis and review of the literature
por: Helvaci, Nafiye, et al.
Publicado: (2017)

Adrenocortical steroid response to ACTH in different phenotypes of non-obese polycystic ovary syndrome
por: Cinar, Nese, et al.
Publicado: (2012)

Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndrome
por: Yang, Young-Mo, et al.
Publicado: (2015)

Impact of social isolation during COVID-19 pandemic on health behaviors and weight management in women with polycystic ovary syndrome
por: Eyupoglu, Nesrin Damla, et al.
Publicado: (2022)

Update on Animal Models of Polycystic Ovary Syndrome
por: Stener-Victorin, Elisabet
Publicado: (2022)

Management of Recurrent Deep Vein Thrombosis in a Transgender Woman
por: Oguz, Seda Hanife, et al.
Publicado: (2021)

The Polycystic Ovary Syndrome: An update on metabolic and hormonal mechanisms
por: Dumitrescu, R, et al.
Publicado: (2015)

Hormonal contraception in women with polycystic ovary syndrome: choices, challenges, and noncontraceptive benefits
por: de Melo, Anderson Sanches, et al.
Publicado: (2017)

The Genetic Basis of the Polycystic Ovary Syndrome: A Literature Review Including Discussion of PPAR-γ
por: Unluturk, Ugur, et al.
Publicado: (2007)

Markers of insulin resistance in Polycystic ovary syndrome women: An update
por: Amisi, Chantal Anifa
Publicado: (2022)

Assessment of Type 2 Diabetes Risk in Young Women with Polycystic Ovary Syndrome
por: Livadas, Sarantis, et al.
Publicado: (2023)

Contraception for Women with Polycystic Ovary Syndrome: Dealing with a Complex Condition
por: Spritzer, Poli Mara
Publicado: (2022)

Endocrine Risk Factors of Endometrial Cancer: Polycystic Ovary Syndrome, Oral Contraceptives, Infertility, Tamoxifen
por: Ignatov, Atanas, et al.
Publicado: (2020)

Update in polycystic ovary syndrome: new criteria of diagnosis and treatment in Japan
por: Kubota, Toshiro
Publicado: (2013)

An update of polycystic ovary syndrome: causes and therapeutics options
por: Rababa’h, Abeer M., et al.
Publicado: (2022)

Relationship between nonalcoholic fatty liver disease and hyperandrogenemia in adolescents with polycystic ovary syndrome
por: Kara, Ozlem, et al.
Publicado: (2023)

MON-205 Is Muscle Mechanical Function Altered In Polycystic Ovary Syndrome?
por: Caliskan Guzelce, Ezgi, et al.
Publicado: (2019)

Renal resistive index in patients with polycystic ovary syndrome
por: Tüfekçioğlu, Gülsen, et al.
Publicado: (2019)

Risks, benefits size and clinical implications of combined oral contraceptive use in women with polycystic ovary syndrome
por: de Medeiros, Sebastião Freitas
Publicado: (2017)

Polycystic Ovary Syndrome in Adolescence
por: Deans, Rebecca
Publicado: (2019)

Polymorphisms in FSHR modulating susceptibility to polycystic ovary syndrome: an updated meta-analysis
por: Kaur, Mandeep, et al.
Publicado: (2023)

Pregnancy in polycystic ovary syndrome
por: Kamalanathan, Sadishkumar, et al.
Publicado: (2013)

Potential for NPY receptor–related therapies for polycystic ovary syndrome: an updated review
por: Chen, Wei-hong, et al.
Publicado: (2023)

Influence of combined oral contraceptives on polycystic ovarian morphology-related parameters in Korean women with polycystic ovary syndrome
por: Park, Chan-Hong, et al.
Publicado: (2020)

Anterior Segment Findings in Women with Polycystic Ovary Syndrome
por: Karaca Adıyeke, Seda, et al.
Publicado: (2017)

Polycystic Ovary Syndrome: An Updated Overview Foregrounding Impacts of Ethnicities and Geographic Variations
por: Yasmin, Afrin, et al.
Publicado: (2022)

Updating the polycystic ovary syndrome diagnosis: Does ultrasound matter?
por: Komorowski, Allison S., et al.
Publicado: (2023)

Estrogen Receptors in Polycystic Ovary Syndrome
por: Xu, Xue-Ling, et al.
Publicado: (2021)

Treatment options for polycystic ovary syndrome
por: Badawy, Ahmed, et al.
Publicado: (2011)

Features of Polycystic Ovary Syndrome in adolescence
por: Tsikouras, P, et al.
Publicado: (2015)

Dyslipidemia in women with polycystic ovary syndrome
por: Kim, Jin Ju, et al.
Publicado: (2013)

Cardiometabolic risk in polycystic ovary syndrome
por: Bajuk Studen, Katica, et al.
Publicado: (2018)

Polycystic ovary syndrome and mitochondrial dysfunction
por: Zhang, Jingshun, et al.
Publicado: (2019)

Polycystic Ovary Syndrome and Gender Identity
por: Liu, Minghao, et al.
Publicado: (2020)

Neuroendocrine Determinants of Polycystic Ovary Syndrome
por: Szeliga, Anna, et al.
Publicado: (2022)

Dietary supplements for polycystic ovary syndrome
por: KIANI, AYSHA KARIM, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2rvvd9i2u7mu9p6j2ac2rfijir